Expression of miRNA and Occurrence of Distant Metastases in Patients with Hürthle Cell Carcinoma

Background. Hürthle cell thyroid carcinoma (HCTC) is a rare type of thyroid carcinoma. In the present study, we investigated whether the expression of miRNAs of interest is associated with the occurrence of metastases in patients with HCTC. Materials and Methods. In 39 patients with HCTC (22 with no...

Full description

Saved in:
Bibliographic Details
Main Authors: Rok Petric, Barbara Gazic, Katja Goricar, Vita Dolzan, Radan Dzodic, Nikola Besic
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:International Journal of Endocrinology
Online Access:http://dx.doi.org/10.1155/2016/8945247
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832566981840076800
author Rok Petric
Barbara Gazic
Katja Goricar
Vita Dolzan
Radan Dzodic
Nikola Besic
author_facet Rok Petric
Barbara Gazic
Katja Goricar
Vita Dolzan
Radan Dzodic
Nikola Besic
author_sort Rok Petric
collection DOAJ
description Background. Hürthle cell thyroid carcinoma (HCTC) is a rare type of thyroid carcinoma. In the present study, we investigated whether the expression of miRNAs of interest is associated with the occurrence of metastases in patients with HCTC. Materials and Methods. In 39 patients with HCTC (22 with nonmetastatic and 17 with regional or distant metastatic disease), the expression levels of six miRNAs (miR-138, miR-183, miR-221, miR-222, miR-768-3p, and miR-885-5p) and U6 snRNA as endogenous control were determined in FFPE samples of primary tumor and normal thyroid tissue using TaqMan miRNA assays. Results. In patients with HCTC, miR-138 and miR-768-3p were downregulated in tumor samples compared to normal tissue (p=0.013 and p=0.010, resp.). These two miRNAs were also significantly downregulated in tumor samples of patients with metastatic disease (p=0.030 and p=0.048, resp.) but not in patients with nonmetastatic disease (p=0.249 and p=0.101, resp.). In patients with nonmetastatic disease, miR-221 and miR-885-5p were slightly, albeit significantly, upregulated in tumorous compared to normal tissue (p=0.042 and p=0.027, resp.). Conclusion. Expression of miRNA (miR-183, miR-221, and miR-885-5p) in tumor tissue is associated with the occurrence of distant metastases in patients with HCTC.
format Article
id doaj-art-adfe49f1ef1c4b50a1e23355f71a0cd8
institution Kabale University
issn 1687-8337
1687-8345
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series International Journal of Endocrinology
spelling doaj-art-adfe49f1ef1c4b50a1e23355f71a0cd82025-02-03T01:02:39ZengWileyInternational Journal of Endocrinology1687-83371687-83452016-01-01201610.1155/2016/89452478945247Expression of miRNA and Occurrence of Distant Metastases in Patients with Hürthle Cell CarcinomaRok Petric0Barbara Gazic1Katja Goricar2Vita Dolzan3Radan Dzodic4Nikola Besic5Department of Surgical Oncology, Institute of Oncology, Zaloska 2, SL-1000, Ljubljana, SloveniaDepartment of Pathology, Institute of Oncology, Zaloska 2, SL-1000, Ljubljana, SloveniaPharmacogenetics Laboratory, Institute of Biochemistry, Faculty of Medicine, University of Ljubljana, SL-1000, Ljubljana, SloveniaPharmacogenetics Laboratory, Institute of Biochemistry, Faculty of Medicine, University of Ljubljana, SL-1000, Ljubljana, SloveniaDepartment of Surgical Oncology, Institute of Oncology and Radiology of Serbia, Pasterova 2, 11000 Belgrade, SerbiaDepartment of Surgical Oncology, Institute of Oncology, Zaloska 2, SL-1000, Ljubljana, SloveniaBackground. Hürthle cell thyroid carcinoma (HCTC) is a rare type of thyroid carcinoma. In the present study, we investigated whether the expression of miRNAs of interest is associated with the occurrence of metastases in patients with HCTC. Materials and Methods. In 39 patients with HCTC (22 with nonmetastatic and 17 with regional or distant metastatic disease), the expression levels of six miRNAs (miR-138, miR-183, miR-221, miR-222, miR-768-3p, and miR-885-5p) and U6 snRNA as endogenous control were determined in FFPE samples of primary tumor and normal thyroid tissue using TaqMan miRNA assays. Results. In patients with HCTC, miR-138 and miR-768-3p were downregulated in tumor samples compared to normal tissue (p=0.013 and p=0.010, resp.). These two miRNAs were also significantly downregulated in tumor samples of patients with metastatic disease (p=0.030 and p=0.048, resp.) but not in patients with nonmetastatic disease (p=0.249 and p=0.101, resp.). In patients with nonmetastatic disease, miR-221 and miR-885-5p were slightly, albeit significantly, upregulated in tumorous compared to normal tissue (p=0.042 and p=0.027, resp.). Conclusion. Expression of miRNA (miR-183, miR-221, and miR-885-5p) in tumor tissue is associated with the occurrence of distant metastases in patients with HCTC.http://dx.doi.org/10.1155/2016/8945247
spellingShingle Rok Petric
Barbara Gazic
Katja Goricar
Vita Dolzan
Radan Dzodic
Nikola Besic
Expression of miRNA and Occurrence of Distant Metastases in Patients with Hürthle Cell Carcinoma
International Journal of Endocrinology
title Expression of miRNA and Occurrence of Distant Metastases in Patients with Hürthle Cell Carcinoma
title_full Expression of miRNA and Occurrence of Distant Metastases in Patients with Hürthle Cell Carcinoma
title_fullStr Expression of miRNA and Occurrence of Distant Metastases in Patients with Hürthle Cell Carcinoma
title_full_unstemmed Expression of miRNA and Occurrence of Distant Metastases in Patients with Hürthle Cell Carcinoma
title_short Expression of miRNA and Occurrence of Distant Metastases in Patients with Hürthle Cell Carcinoma
title_sort expression of mirna and occurrence of distant metastases in patients with hurthle cell carcinoma
url http://dx.doi.org/10.1155/2016/8945247
work_keys_str_mv AT rokpetric expressionofmirnaandoccurrenceofdistantmetastasesinpatientswithhurthlecellcarcinoma
AT barbaragazic expressionofmirnaandoccurrenceofdistantmetastasesinpatientswithhurthlecellcarcinoma
AT katjagoricar expressionofmirnaandoccurrenceofdistantmetastasesinpatientswithhurthlecellcarcinoma
AT vitadolzan expressionofmirnaandoccurrenceofdistantmetastasesinpatientswithhurthlecellcarcinoma
AT radandzodic expressionofmirnaandoccurrenceofdistantmetastasesinpatientswithhurthlecellcarcinoma
AT nikolabesic expressionofmirnaandoccurrenceofdistantmetastasesinpatientswithhurthlecellcarcinoma